Drugs / Ortho Tri-Cyclen LO
Regulatory milestones approvals, filings & regulatory actions · 1 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | US (FDA) | ORTHO TRI-CYCLEN LO | — | 2002-08-22 | fda.gov ↗ |
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy2 trials | ||||||
| Phase 1 | NCT00399685 Comparator | Dec 2006 → Aug 2007 | HIV infectious disease | Bristol-Myers Squibb | Completed | No outcome recorded |
| Phase 4 | NCT00635570 Comparator | Jul 2008 → Jan 2009 | — | University of Chicago | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ortho Tri-Cyclen LO | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00399685 ↗ |
| Route | Oral | “Tablets, oral” NCT00399685 ↗ |